Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Stage IIIB or IV Non-Small Cell Lung Cancer × Vorinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stage IIIB or IV Non-Small Cell Lung Cancer 1 Spinal Cord Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma 1 Leukemia 1 Astrocytoma 1

Interventions

Vorinostat 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473889 2015-07-03

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Merck Sharp & Dohme LLC

Phase 2/3 Terminated

253 enrolled 13 charts

Stage IIIB or IV Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡